Related by context. Frequent words. (Click for all words.) 63 TELCYTA 63 phase IIb 63 active comparator 61 dose cohorts 60 Phase 2b study 60 CoFactor 60 FavId 60 PS# [001] 60 ADVEXIN 60 Zerenex 60 vicriviroc 59 peginterferon alfa 2b 59 Phase 2b clinical 59 Phase 2a trial 59 Phase 2b trial 59 Phase 1b trial 59 Phase III 59 alvimopan 58 BCX# 58 phase 2a 58 NUVIGIL 58 Phase 2a clinical 58 phase IIa 58 Amigal 58 PREOS 58 methylnaltrexone 58 sapacitabine 58 PF # [001] 58 teduglutide 58 MOZOBIL 58 AP# [003] 58 valopicitabine 57 rNAPc2 57 Phenoptin 57 Taxotere R 57 Phase III clinical 57 panitumumab 57 Pharmacokinetic 57 dose regimens 57 dose escalation trial 57 Phase Ib 57 ISENTRESS 57 safety tolerability pharmacokinetics 57 palifosfamide 57 JANUVIA 57 BAY #-# 57 lubiprostone 57 SCH # 56 Phase 1b 56 clinical endpoints 56 HGS ETR1 56 RG# [001] 56 6R BH4 56 noninferiority 56 PROMACTA 56 pivotal Phase III 56 pharmacodynamics 56 Taxotere ® 56 PXD# 56 mg doses 56 placebo controlled randomized 56 Vilazodone 56 elagolix 56 dosing regimens 56 Phase IIb 56 nitazoxanide 56 imetelstat 55 INCB# [002] 55 LymphoStat B 55 pharmacokinetic studies 55 SILENOR TM 55 belinostat 55 pharmacodynamic 55 tamibarotene 55 picoplatin 55 Phase IIa trial 55 rHuPH# 55 rotigotine 55 confirmatory Phase III 55 GVAX 55 ZYBRESTAT 55 telbivudine 55 efficacy endpoints 55 non inferiority 55 Phase Ia 55 Phase IIb clinical 55 Genasense 55 pharmacokinetic 55 Biologics License Application 55 bazedoxifene 55 Phase 2b 55 randomized Phase III 55 ALN VSP 55 Marqibo 55 multicenter clinical 55 Phase 1b clinical 55 relapsed multiple myeloma 55 Phase IIa 55 IPX# 55 TORISEL 55 refractory multiple myeloma